Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELATE and PREDICT TRD
NL-OMON27079Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of escitalopram and nortriptyline in major depressive disorder (MDD) and treatment-resistant depression (TRD) (4 arms), sponsored by University Medical Center Groningen. Primary endpoints: Change in Hamilton Depression Rating Scale 17-item score, Response and remission by HDRS17 and 3 more. Planned start Jun 2013; status: not yet recruiting.
02
Drugs
escitalopramnortriptyline
03
Conditions
major depressive disorder (MDD)treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NL-OMON27079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27079.